India covid-19 SOLIDARITY patient India

Covid-19: WHO discontinues hydroxychloroquine, lopinavir/ritonavir treatment arm

Reading now: 216
www.livemint.com

WHO said in a statement on Saturday.For each of the drugs, the interim results do not provide solid evidence of increased mortality.

There were, however, some associated safety signals in the clinical laboratory findings of the add-on Discovery trial, a participant in the Solidarity trial.

These will also be reported in the peer-reviewed publication.This decision applies only to the conduct of the Solidarity Trial in hospitalized patients and does not affect the possible evaluation in other studies of hydroxychloroquine or lopinavir/ritonavir in non-hospitalized patients or as pre- or post-exposure prophylaxis for covid-19, the WHO said.Of 6,71,680 cases reported in India till Saturday, 2,35,433 are active.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA